Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine in Myasthenia Gravis
NCT03510546Phase 4Unknown
- Sponsor
- Aarhus University
- Start
- Apr 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pyridostigmine in myasthenia gravis (MG), sponsored by Aarhus University. Status: unknown.
02
Drugs
pyridostigmine
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT03510546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03510546.